-
Je něco špatně v tomto záznamu ?
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
P. Peichl, A. Bayes-Genis, T. Deneke, O. Chioncel, M. deRiva, MG. Crespo-Leiro, A. Frontera, F. Gustafsson, RP. Martins, M. Pagnesi, P. Maury, MC. Petrie, F. Sacher, O. Amir, L. Di Biase, I. Deisenhofer, A. Gasparetti, M. Hocini, FM. Costa, B....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
NLK
Free Medical Journals
od 1999 do Před 1 rokem
PubMed Central
od 2008
Open Access Digital Library
od 1999-01-01
Medline Complete (EBSCOhost)
od 1999-01-01
Oxford Journals Open Access Collection
od 1999-01-01
PubMed
39478667
DOI
10.1093/europace/euae272
Knihovny.cz E-zdroje
- MeSH
- antiarytmika * terapeutické užití MeSH
- funkce levé komory srdeční MeSH
- katetrizační ablace * metody MeSH
- komorová tachykardie terapie chirurgie patofyziologie MeSH
- konsensus MeSH
- lidé MeSH
- podpůrné srdeční systémy * MeSH
- rizikové faktory MeSH
- srdeční arytmie * terapie patofyziologie diagnóza MeSH
- srdeční selhání * terapie patofyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure. Although these devices effectively improve survival, atrial and ventricular arrhythmias are common with a prevalence of 20-50% at one year after LVAD implantation. Arrhythmias predispose these patients to additional risk and are associated with considerable morbidity from recurrent implantable cardioverter-defibrillator shocks, progressive failure of the unsupported right ventricle, and herald an increased risk of mortality. Management of patients with arrhythmias and LVAD differs in many aspects from the general population heart failure patients. These include ruling out the reversible causes of arrhythmias that in LVAD patients may include mechanical irritation from the inflow cannula and suction events. For patients with symptomatic arrhythmias refractory to medical treatment, catheter ablation might be relevant. There are specific technical and procedural challenges perceived to be unique to LVAD-related ventricular tachycardia (VT) ablation such as vascular and LV access, signal filtering, catheter manoeuvrability within decompressed chambers, and electroanatomic mapping system interference. In some patients, the arrhythmogenic substrate might not be readily accessible by catheter ablation after LVAD implantation. In this regard, the peri-implantation period offers a unique opportunity to surgically address arrhythmogenic substrate and suppress future VT recurrences. This document aims to address specific aspects of the management of arrhythmias in LVAD patients focusing on anti-arrhythmic drug therapy and ablations.
Armed Forces Hospital Porto Portugal
Cardiopulmonary Department San Raffaele Open University of Rome IRCCS San Raffaele Roma Roma Italy
Complexo Hospitalario Universitario A Coruña A Coruña Spain
Department of Cardiac Electrophysiology Great Metropolitan Hospital Niguarda Milan Italy
Department of Cardiology Hospital de Santa Cruz Carnaxide Lisbon Portugal
Department of Cardiology IKEM Vídeňská 1958 9 Prague Czech Republic
Department of Cardiology Rangueil Hospital of Toulouse Toulouse France
Department of Cardiology Rigshospitalet Denmark
Department of Cardiology University Hospital of Rennes Rennes France
Faculty of Medicine of the University of Porto Portugal
Heart Center Hadassah Medical Center and Hebrew University Jerusalem Israel
Heart Institute at Hospital Universitari Germans Trias i Pujol CIBERCV Badalona Spain
Institute of Emergency for Cardiovascular Diseases 'C C Iliescu' Bucharest Romania
Leiden University Medical Center Leiden The Netherlands
Montefiore Medical Center Albert Einstein College of Medicine Bronx NY USA
School of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK
School of Medicine Balamand University Beirut Lebanon Abu Dhabi UAE
School of Medicine Johns Hopkins University Baltimore MD USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003578
- 003
- CZ-PrNML
- 005
- 20250206104426.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/europace/euae272 $2 doi
- 035 __
- $a (PubMed)39478667
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Peichl, Petr $u Department of Cardiology, IKEM, Vídeňská 1958/9, Prague, Czech Republic $1 https://orcid.org/0000000256250071 $7 xx0092197
- 245 10
- $a Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC / $c P. Peichl, A. Bayes-Genis, T. Deneke, O. Chioncel, M. deRiva, MG. Crespo-Leiro, A. Frontera, F. Gustafsson, RP. Martins, M. Pagnesi, P. Maury, MC. Petrie, F. Sacher, O. Amir, L. Di Biase, I. Deisenhofer, A. Gasparetti, M. Hocini, FM. Costa, B. Moura, H. Skouri, CG. Tocchetti, M. Volterrani, R. Wakili
- 520 9_
- $a Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure. Although these devices effectively improve survival, atrial and ventricular arrhythmias are common with a prevalence of 20-50% at one year after LVAD implantation. Arrhythmias predispose these patients to additional risk and are associated with considerable morbidity from recurrent implantable cardioverter-defibrillator shocks, progressive failure of the unsupported right ventricle, and herald an increased risk of mortality. Management of patients with arrhythmias and LVAD differs in many aspects from the general population heart failure patients. These include ruling out the reversible causes of arrhythmias that in LVAD patients may include mechanical irritation from the inflow cannula and suction events. For patients with symptomatic arrhythmias refractory to medical treatment, catheter ablation might be relevant. There are specific technical and procedural challenges perceived to be unique to LVAD-related ventricular tachycardia (VT) ablation such as vascular and LV access, signal filtering, catheter manoeuvrability within decompressed chambers, and electroanatomic mapping system interference. In some patients, the arrhythmogenic substrate might not be readily accessible by catheter ablation after LVAD implantation. In this regard, the peri-implantation period offers a unique opportunity to surgically address arrhythmogenic substrate and suppress future VT recurrences. This document aims to address specific aspects of the management of arrhythmias in LVAD patients focusing on anti-arrhythmic drug therapy and ablations.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a antiarytmika $x terapeutické užití $7 D000889
- 650 12
- $a srdeční arytmie $x terapie $x patofyziologie $x diagnóza $7 D001145
- 650 12
- $a katetrizační ablace $x metody $7 D017115
- 650 _2
- $a konsensus $7 D032921
- 650 12
- $a srdeční selhání $x terapie $x patofyziologie $7 D006333
- 650 12
- $a podpůrné srdeční systémy $7 D006353
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a komorová tachykardie $x terapie $x chirurgie $x patofyziologie $7 D017180
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a funkce levé komory srdeční $7 D016277
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Bayes-Genis, Antoni $u Heart Institute at Hospital Universitari Germans Trias i Pujol, CIBERCV, Badalona, Spain $1 https://orcid.org/000000023044197X
- 700 1_
- $a Deneke, Thomas $u Clinic for Arrhythmology, Klinikum Nuernberg Süd, University Hospital of the Paracelsus Medical University, Nuernberg, Germany $1 https://orcid.org/0000000313791684
- 700 1_
- $a Chioncel, Ovidiu $u Institute of Emergency for Cardiovascular Diseases, 'C.C.Iliescu' Bucharest, Romania $u University of Medicine Carol Davila, Bucharest, Romania $1 https://orcid.org/0000000231973628
- 700 1_
- $a deRiva, Marta $u Leiden University Medical Center, Leiden, The Netherlands $1 https://orcid.org/0000000258786750
- 700 1_
- $a Crespo-Leiro, Maria Generosa $u Complexo Hospitalario Universitario A Coruña (CHUAC)-CIBERCV, Instituto de Investigación Biomedica A Coruña (INIBIC), Universidad de A Coruña (UDC), A Coruña, Spain $1 https://orcid.org/000000023085167X
- 700 1_
- $a Frontera, Antonio $u Department of Cardiac Electrophysiology, Great Metropolitan Hospital Niguarda, Milan, Italy $1 https://orcid.org/0000000203724480
- 700 1_
- $a Gustafsson, Finn $u Department of Cardiology, Rigshospitalet, Denmark $1 https://orcid.org/000000032144341X
- 700 1_
- $a Martins, Raphaël P $u Department of Cardiology, University Hospital of Rennes, Rennes, France $1 https://orcid.org/0000000157166712
- 700 1_
- $a Pagnesi, Matteo $u Department of Medical and Surgical Specialties, Radiological sciences and Public Health, Institute of Cardiology, ASST Spedali Civili, University of Brescia, Brescia, Italy $1 https://orcid.org/0000000292987871
- 700 1_
- $a Maury, Philippe $u Department of Cardiology, Rangueil Hospital of Toulouse, Toulouse, France $1 https://orcid.org/0000000248001841
- 700 1_
- $a Petrie, Mark C $u School of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK $1 https://orcid.org/0000000263339496
- 700 1_
- $a Sacher, Frederic $u Cardiac Arrhythmia Department, Univ. Bordeaux, CHU de Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, Bordeaux, France $1 https://orcid.org/0000000183489320
- 700 1_
- $a Amir, Offer $u Heart Center, Hadassah Medical Center and Hebrew University, Jerusalem, Israel $1 https://orcid.org/0000000256242450
- 700 1_
- $a Di Biase, Luigi $u Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
- 700 1_
- $a Deisenhofer, Isabel $u Department of Electrophysiology, German Heart Center Munich, Technical University of Munich, Munich, Germany
- 700 1_
- $a Gasparetti, Alessio $u School of Medicine, Johns Hopkins University, Baltimore, MD, USA
- 700 1_
- $a Hocini, Mélèze $u Hôpital cardiologique du Haut Lévêque, Cardiology-Cardiac Electrophysiology Department, Pessac, France and IHU Liryc-L'Institut des maladies du rythme cardiaque, Site Hôpital Xavier Arnozan, Pessac, France
- 700 1_
- $a Costa, Francisco Moscoso $u Department of Cardiology, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal
- 700 1_
- $a Moura, Brenda $u Armed Forces Hospital, Porto, Portugal $u Faculty of Medicine of the University of Porto, Portugal
- 700 1_
- $a Skouri, Hadi $u School of Medicine, Balamand University, Beirut-Lebanon, Abu Dhabi, UAE $u Sheikh Shakhbout Medical City, Abu Dhabi, UAE
- 700 1_
- $a Tocchetti, Carlo Gabriele $u Internal Medicine Unit for Cancer Patients, Department of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center for Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, NA, Italy
- 700 1_
- $a Volterrani, Maurizio $u Cardiopulmonary Department, San Raffaele Open University of Rome, IRCCS San Raffaele Roma, Roma, Italy
- 700 1_
- $a Wakili, Reza $u Department of Cardiology and Vascular Medicine, University Hospital Frankfurt, Goethe-University Frankfurt, ZIM-Med. Klinik 3-Kardiologie, Angiologie, Frankfurt am Main, Germany
- 773 0_
- $w MED00149837 $t Europace $x 1532-2092 $g Roč. 26, č. 11 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39478667 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104421 $b ABA008
- 999 __
- $a ok $b bmc $g 2263370 $s 1239585
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 26 $c 11 $e 20241101 $i 1532-2092 $m Europace $n Europace $x MED00149837
- LZP __
- $a Pubmed-20250121
